# Laurie H. Sehn

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/laurie-h-sehn/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,023 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 84 |
| i10-index | 283 |
| Last Known Institution | BC Cancer Agency |
| OpenAlex ID | https://openalex.org/A5026641386 |
| ORCID iD | https://orcid.org/0000-0003-1860-9765 |
| Works | 657 |

## Researcher papers

- [An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era](https://scholariq.org/papers/an-enhanced-international-prognostic-index-nccn-ipi-for-patients-with-diffuse/)
- [Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma](https://scholariq.org/papers/polatuzumab-vedotin-in-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/)
- [Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma](https://scholariq.org/papers/rituximab-plus-lenalidomide-in-advanced-untreated-follicular-lymphoma/)
- [Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study](https://scholariq.org/papers/safety-and-activity-of-the-anti-cd79b-antibody-drug-conjugate-polatuzumab/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [CNS Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/cns-lymphoma-diagnosis-and-treatment/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders-2/)

## Researcher university

- [BC Cancer Agency](https://scholariq.org/institutions/bc-cancer-agency/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.